Kidney removal debate settled? major trial tests surgery plus drug vs. drug alone
NCT ID NCT00930033
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 27 times
Summary
This study looked at whether removing the cancerous kidney (nephrectomy) before starting the drug sunitinib helps people with metastatic kidney cancer live longer. About 450 adults with clear cell kidney cancer that had spread were randomly assigned to have surgery plus sunitinib or sunitinib alone. The main goal was to compare overall survival between the two groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC RENAL CELL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hopital Necker
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.